|
FDA Finds Increased Minimization, Omission of Risk Info in Drug Promos
PHILADELPHIA — Drug and medical device companies are increasingly minimizing or omitting the risks associated with their products in advertising and promotional materials this year, an FDA official says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
|
Subscribe
Archives